Author: Abhay Panchal

In 2025, healthcare will continue to evolve with advancements in AI, biotechnology, and personalized medicine driving significant changes in planning and delivery. Personalized healthcare will focus on tailoring wellness plans using AI and data, shifting from reactive to preventative care to improve outcomes and reduce costs. Innovations like brain-computer interfaces and CRISPR gene editing will revolutionize treatments for chronic and genetic conditions, though ethical and data security concerns will grow as health data volume increases.Addressing the tech skills gap will be crucial as healthcare organizations invest in training and partnerships to harness new technologies effectively.

Read More

Frazier Healthcare Partners has closed its $2.3 billion flagship fund, Frazier Healthcare Growth Buyout Fund XI (FHGB XI), reaching its hard cap in just six months due to strong investor demand. The fund will focus on acquiring controlling stakes in middle-market healthcare companies.The Seattle-based private equity firm, with over 30 years of healthcare-focused investment experience, secured commitments from a range of global investors, including sovereign wealth funds, public pension funds, and endowments. Notably, the New Mexico State Investment Council contributed $150 million, with an additional $150 million allocated for co-investments.

Read More

Lucid Diagnostics has submitted its complete clinical evidence package to Medicare’s Molecular Diagnostics Program (MolDX), seeking reconsideration of a Local Coverage Determination (LCD) to secure Medicare coverage for its EsoGuard® Esophageal DNA Test. EsoGuard is a noninvasive diagnostic tool designed to detect esophageal precancer in patients with gastroesophageal reflux disease (GERD). The submission includes six peer-reviewed studies demonstrating the test’s clinical validity, utility, and analytical accuracy.

Read More

The incoming Trump Administration and Republican-controlled Congress will significantly shape healthcare policies in 2025, emphasizing deregulation and reshaping initiatives from the Biden era. Key areas to watch include: While the regulatory environment may present challenges, opportunities exist for stakeholders advocating reduced regulation, faster innovation, and patient-focused initiatives.

Read More

In this podcast, Tom Serena, CEO of the American Gastroenterological Association (AGA), reflects on his journey in leadership and the evolving role of private equity in the GI field. Serena discusses his upbringing, career milestones, and the shift in AGA’s culture toward inclusivity. He highlights the GI Opportunity Fund’s partnership with venture capital to drive innovation and shares insights on challenges like physician burnout, autonomy, and reimbursement. Serena also touches on how legacy societies adapt to emerging specialized organizations and shares valuable life lessons from his 30 years with AGA.

Read More

Doctors dominate the list of highest-paid U.S. occupations, holding 16 of the top 20 positions, with pediatric surgeons earning $449,320 on average. Dentists fill the other four slots. The reasons for these high earnings include extensive education, long hours, and a restricted supply of doctors due to caps on medical school seats and residencies, leading to elevated salaries.Additionally, federal policies, such as Medicare pricing, allocate significant resources to healthcare, which drives costs and salaries higher. Despite their high incomes, doctors face challenges like student debt, burnout, and a growing physician shortage, with only 2.7 doctors per 1,000 people in the…

Read More

Dr. Nitesh Ratnakar, a gastroenterologist from Wheeling, West Virginia, has been convicted of 41 counts of tax fraud for failing to remit nearly $2.5 million in payroll taxes. Operating a gastroenterology practice and a medical equipment manufacturing company in Elkins, West Virginia, Dr. Ratnakar withheld payroll taxes from employees’ paychecks between 2018 and 2022 but did not forward these funds to the Internal Revenue Service (IRS).

Read More

The American Gastroenterological Association (AGA) has released updated guidelines for managing moderate-to-severe ulcerative colitis (UC), emphasizing advanced pharmacological therapies and personalized treatment approaches. The guidelines recommend using medications such as infliximab, vedolizumab, and upadacitinib over no treatment and suggest prioritizing higher-efficacy medications, particularly for patients naive to advanced therapies or with prior therapy failures. Combination therapy with TNF antagonists and immunomodulators is preferred, but withdrawal of TNF antagonists is discouraged for patients in sustained remission.

Read More

Bracco Diagnostics Inc. (BDI) and ColoWatch have partnered to expand access to virtual colonoscopy as a colorectal cancer (CRC) screening tool. With the rise in CRC cases among younger patients and low screening rates for those aged 45-49, this collaboration aims to make the less invasive, highly accurate virtual colonoscopy more widely available, especially in underserved communities. The partnership is bolstered by recent CMS proposals for Medicare reimbursement, which could significantly enhance adoption.

Read More